ISRCTN18820528进行中（未招募）未知
Biomarkers of Relapse In ulcerative colitis patients after Tofacitinib dose rEduction (BRITE)
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Aged 18 years or over, either male or female
- •2. A history of ulcerative colitis, as defined by standard clinical criteria
- •3. Patients who are having their tofacitinib dose reduced from 10mg BD to 5mg BD in view of adequate response, as decided by their treating clinical team, and are undergoing routine endoscopy.
- •4. Sufficient English language skills to understand the patient information sheet and consent form.
排除标准
- •1.Patients undergoing dose reduction for reasons other than adequate response to 10mg bd (ie. active infection or VTE risk).
- •2. Patients being dose reduced without undergoing endoscopy
- •3. Patients with insufficient English language skills to understand the patient information sheet and consent form.
研究者
相似试验
Unknown
不适用
Predicting Relapse of Ulcerative Colitis With Gastrointestinal UltrasoundUlcerative Colitis in RemissionUltrasoundRelapse/RecurrenceNCT03501758Haukeland University Hospital40
Unknown
不适用
The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative ColitisIBD, Non Invasive Markers,IL6,Lactoferrin,FerritinNCT04670250Assiut University160
已完成
不适用
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.Ulcerative ColitisNCT05728008IRCCS San Raffaele100
已完成
不适用
Thermography in Surveillance of Ulcerative ColitisUlcerative ColitisNCT02149043University Hospital Dubrava66
尚未招募
Unknown
Can AI predict the prognosis of ulcerative colitis?lcerative colitisJPRN-UMIN000049858Tokyo Women's Medical University70